PHYSTA CLINICAL STUDIES
Backed by 28 human clinical trials, Physta® standardized extract is scientifically proven to ensure safety, efficacy, and consistent quality for men's vitality.
Muscle Strength & Mass
Hamzah, et al., 2002
Bicep muscle circumference increased significantly. Results suggest Physta® can have an anabolic effect on muscle cells.
Strength (Men)
Hamzah, et al., 2003
Significant improvement in lean body mass. Percentage of body fat was significantly decreased.
Safety up to 600 mg
Tambi, et al., 2005
No Changes in blood chemistry. Non-toxic at high dose of 600mg and successfully reduces aging male symptoms.
QoL (Aging Men)
Tambi, et al.
Majority showed increased sexual desire and the success in the attempts at sexual intercourse.
Strength (Women)
Sarina, et al., 2009
Significant improvement in bench press & leg press. Greater gains in handgrip strength.
Endurance & Metabolism
Muhamad, et al., 2010
No significant effect was observed on endurance running performance in recreational athletes for 7 days.
Fertility (Men)
Tambi, et al., 2010
Improvements in sperm parameters including morphology, volume, and concentration. 11 spontaneous pregnancies recorded.
Late-Onset Hypogonadism
Tambi, et al., 2010
Significant improvement in serum testosterone concentration (46.8%). AMS score reduced by 38%.
Men's Health, QoL & Strength
Ismail, et al., 2012 / George, et al., 2013
Higher scores in erectile function and muscle strength while maintaining a safe testosterone-to-epitestosterone ratio.
Stress & Testosterone
Talbott, et al., 2013
Significant improvements for Tension, Anger, and Confusion. Increased salivary testosterone by 37%.
Senior Strength & Testo
Henkel, et al., 2014
Significant increases in total testosterone and free testosterone in active male and female seniors.
Testosterone & ED
Udani, et al., 2014
Improvements in Erection Hardness Scale (39%), SHIM (26%), and Aging Male Symptom scale.
Non-Doping (Athletes)
Chen, et al., 2014
Does not affect urinary testosterone to epitestosterone ratio, liver and renal functions in athletes.
Strength & Immune
Ooi, et al., 2015
Combined with training, it elicits a more beneficial effect on muscular strength and power.
Immune Support
Muhamad, et al., 2015
Natural killer (NK) cells count was significantly higher at the end of the trial, improving immunity.
Lipolysis (Fat Loss)
Lim, et al., 2016
Reduces body weight and fat mass, accompanied by biochemical evidence of increased lipolysis.
Immunity in Middle-Age
George, et al., 2016
SIV and immunological grade were significantly higher. Able to improve immunity-related parameters.
Quality of Life & Stress
George, et al., 2018
Improvement in SF-12 QoL, POMS, MMSQ questionnaires related to stress, emotional and physical functions.
Strength & Power
Chen, et al., 2019
Mean average power of knee flexion and peak power increased significantly with resistance training.
Menopause & QoL
Chinnappan, et al., 2020
Significant improvement in hot flush symptoms and reductions in serum LDL and triglycerides levels.
Muscle Thickness
Zakaria, et al., 2020
Higher % of improvement seen in muscle thickness for EL group. Testosterone trend improved (+20.9%).
Testo & Recovery (Aging)
Chinnappan, et al., 2021
Significantly increased testosterone. AMS showed significant reduction in total scores (up to 50%).
Reproductive Hormones
Chan, et al., 2021
Significant improvement for testosterone (15%), free testosterone (34%) and estradiol (30%) levels.
Strength & Testosterone
Leitão, et al., 2021
Concurrent training combined with Physta yields the most significant improvements in erectile function.
Sports Recovery
Zakaria, et al., 2023
May help buffer the body against exercise-induced hormonal stress, potentially aiding post-exercise recovery.
Anabolic Balance
Talbott, et al., 2024
Significant increase in salivary testosterone (16.4%) and reduction in salivary cortisol level (32.3%).
Menopause & Libido
Muniandy, et al., 2025
Significantly reduced total MENQOL scores with notable improvements in physical and sexual domains.
Gut Microbiome
Reichelt, et al., 2025
Improvements in diversity and target bacterial group ie. Bifidobacteria and Lactobacilli.
Indication
Study Title Goes Here
Author, Year | Subjects | Dose
Key Findings & Outcomes:
POWERED BY
© 2026 – Biotropics Malaysia.
All rights reserved. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.